Piotr Wieniawski

Dr. Piotr Wieniawski

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
PWPiotr Wieniawski
Piotr Wieniawski
Bożena WernerBożena Werner
Bożena Werner
The aim of this cross-sectional study was to assess the prevalence of abnormal weight and anthropometric parameters along with abnormal blood pressure values in adolescents in Poland. Anthropometric measurements were taken in the studied age group and the correlation between these values and blood pressure values and the diagnosis of hypertension was analyzed. The main aim of the study was to characterize the particular age group in the selected population: 690 students aged 15–17 years were examined. Blood pressure and anthropometric values including height, weight, circumferences of the hips, abdomen and arms, as well as skinfolds on the back of the arm, below the scapula and the stomach, were taken. The following indexes were calculated: WHR (waist to hip ratio), WHtR (waist to height ratio), BAI (body adiposity index-hip to height ratio) and BMI (body mass index). Mean SBP (systolic blood pressure) was 112.3 (standard deviation (SD) 12.2) mmHg, and DBP (diastolic blood pressure) was 66.9 (SD 6.9) mmHg. The prevalence of hypertension in the studied group was 5.8% (3.2% boys, 2.6% girls) and prehypertension was present in 4.4% (1.6% boys, 2.8% girls). The prevalence of excess body weight was 23.6%-obesity 11.3% (40 girls, 27 boys) and overweight 12.3% (50 girls, 34 boys). Correlations between BMI and waist, hip and arm circumference, subscapular and abdominal skinfold thickness, WHtR and BAI were r = 0.86, r = 0.84, r = 0.88, r = 0.81, r = 0.75, r = 0.88 and r = 0.81, respectively (p < 0.05). Significant differences (p < 0.05) of SBP and DBP values, depending on weight category, as defined by BMI, were observed. Abnormal blood pressure values occur in one tenth and abnormal body weight in almost a quarter of the studied population. Obese and overweight children have higher SBP and DBP values compared to children with normal body weight.

PWPiotr Wieniawski
Piotr Wieniawski
MBMichał Buczyński
Michał Buczyński
MGMarcin Grabowski
Marcin Grabowski
JWJoachim Winter
Joachim Winter
Bożena WernerBożena Werner
Bożena Werner
Background: The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the transvenous ICD, to prevent lead-related complications associated with the latter. The absence of intravascular or intracardiac components offers potential advantages to pediatric patients. Aims: The aim of the study is to present an overview of our experience with S-ICDs in the pediatric center that, currently, has performed the largest number of implantations in children in Poland. Methods: Retrospective analysis of data from medical history, qualification, implantation procedure, and S-ICD post-implantation observations in 11 pediatric patients were performed. Results: S-ICDs were implanted in 11 patients, 8 boys and 3 girls, aged 12–17 years. The S-ICD was implanted for primary prevention in seven patients: four with hypertrophic cardiomyopathy (HCM), two with dilated cardiomyopathy (DCM), and one with arrhythmogenic right ventricular cardiomyopathy (ARVC). It was implanted for secondary prevention in four patients: two with sudden cardiac arrest (SCA) in the course of idiopathic ventricular fibrillation (IVF), one with long QT syndrome (LQTS) after probable SCA, and one with Brugada syndrome after SCA. In all patients, the device was implanted intramuscularly. One patient did not have a defibrillation test performed due to the presence of an intracardiac thrombus. In one patient, during screening, it was decided to implant an electrode on the right side of the sternum. There were no early or late complications with any of the procedures. So far, no inadequate discharges have been observed. Conclusions: Our results prove the efficacy of the S-ICD treatment option along with technically simple surgery, which supports its further and more widespread application in children.

8 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Jakub S. GąsiorJakub S. Gąsior
Jakub S. Gąsior
MMMarcel Młyńczak
Marcel Młyńczak
MRMaciej Rosoł
Maciej Rosoł
PWPiotr Wieniawski
Piotr Wieniawski
RPRadosław Pietrzak
Radosław Pietrzak
Bożena WernerBożena Werner
Bożena Werner
Background: Wearable technologies have been developed to measure physiological parameters conveniently. To consider the new measurement device valid, the crucial point is to assess its reliability with the gold standard. The study aimed to assess the validity of the Pneumonitor (PM, fs = 250 Hz) for acquisition of 5 min RR intervals (RRi) for analysis of heart rate asymmetry (HRA) in relation to the electrocardiography (ECG, fs = 1000 Hz) in a group of 19 pediatric cardiac patients. Association between HRA and respiratory rate (RespRate) was verified. Methods: The validation comprised Bland–Altman analysis, intraclass correlation coefficient, and Student’s t-test. Results: Sufficient agreement between 10 from 16 HRA parameters was observed. Different HRA parameters values calculated based on RRi from both devices were related to different results of correlation analysis between two parameters and RespRate. Conclusions: The PM might be considered valid for recording RRi, which are then processed to calculate selected HRA parameters in a group of pediatric cardiac patients in rest condition. However, RRi recorded using devices with fs < 250 Hz may be not adequate for reliable HRA analysis.

10 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MWMagdalena Warych
Magdalena Warych
JZJakub Zablocki
Jakub Zablocki
JKJulia Krawczyk
Julia Krawczyk
JHJan Herc
Jan Herc
PWPiotr Wieniawski
Piotr Wieniawski
RPRadosław Pietrzak
Radosław Pietrzak
Background/Objectives: Portable and wearable ECG technologies are increasingly used in adult cardiac monitoring. However, evidence supporting their feasibility and diagnostic performance in pediatric populations remains limited. This systematic review evaluates the diagnostic accuracy, usability, artifact susceptibility, and user acceptance of mobile ECG technologies in pediatric cardiology. Methods: A systematic literature search was performed in the Embase, PubMed, Scopus, and Web of Science databases. The review was conducted in accordance with the PRISMA 2020 guidelines and was registered in the PROSPERO database. Results: A total of 30 publications were included in the final analysis. Portable ECG devices demonstrated good feasibility diagnostic utility in children. Handheld systems provided high-quality tracings with strong agreement with standard 12-lead ECGs and higher adherence, as well as user satisfaction compared with conventional event recorders. However, automated rhythm classification frequently misidentified pediatric arrhythmias. Smartwatch-based ECG recordings showed high diagnostic accuracy when manually interpreted, but automated algorithms were unreliable, particularly for tachyarrhythmias and conduction abnormalities. Alternative electrode placement strategies improved smartwatch performance, and patient acceptance was consistently high. ECG patch monitoring, particularly with extended-wear devices, achieved the highest diagnostic yield, detecting arrhythmias often missed by short-duration Holter monitoring while maintaining comparable signal quality. Conclusions: Mobile ECG technologies represent a promising adjunct for pediatric rhythm surveillance, offering diagnostic performance comparable to standard modalities when interpreted by clinicians and improved usability and patient acceptance. Persistent limitations include the poor reliability of adult-oriented automated algorithms and the underrepresentation of younger children and the predominantly off-label use of these devices in pediatric populations, underscoring the need for pediatric-specific algorithm development and age-adapted device design.

7 January 2026 in Journal of Electrocardiology
Verified
Journal Article
Closed access
JZJakub Zabłocki
Jakub Zabłocki
MWMagdalena Warych
Magdalena Warych
JKJulia Krawczyk
Julia Krawczyk
JHJan Herc
Jan Herc
PWPiotr Wieniawski
Piotr Wieniawski
BWBożena Werner
Bożena Werner

Verified
Journal Article
Open access
PDF file
PWPiotr Wieniawski
Piotr Wieniawski
Jakub S. GąsiorJakub S. Gąsior
Jakub S. Gąsior
MRMaciej Rosoł
Maciej Rosoł
MMMarcel Młyńczak
Marcel Młyńczak
ESEwa Smereczyńska-Wierzbicka
Ewa Smereczyńska-Wierzbicka
RPRadosław Pietrzak
Radosław Pietrzak
Vasovagal syncope (VVS) affects 17% of children, significantly impairing quality of life. Machine learning (ML) models achieve high predictive accuracy of VVS in adults using blood pressure (BP) monitoring, but pediatric implementation remains challenging. The aim of the study was to evaluate whether ML models incorporating anthropometric data and heart rate variability (HRV) can predict VVS without BP monitoring in children with prior syncope or suspected VVS. We analyzed 87 participants (7–18 years) with VVS history. HRV indices (time-domain, frequency-domain, and nonlinear) were extracted from 5 min supine and standing ECG recordings using NeuroKit2. Multiple algorithms were tested with 10-fold cross-validation; SHAP analysis identified feature importance. AdaBoost achieved the performance of 71.0% accuracy, 76.3% sensitivity, and 63.3% specificity—78% of adult BP-dependent algorithm sensitivity. Weight, multifractal detrended fluctuation analysis during standing, and normalized low-frequency power were most influential. Alterations in symbolic dynamics and multiscale entropy indicated compromised autonomic complexity. ML models with anthropometric and HRV data show potential as an adjunctive screening tool to identify children at higher risk for syncope recurrence, requiring clinical confirmation.